Supply shortage of new antiviral drug threatens fight against omicron
| A new pill from Pfizer to treat COVID-19 has been hailed as a game-changer that can drastically cut down the number of hospitalizations and deaths from the disease.
But demand for the treatment, known as Paxlovid, is expected to far outrun supply, blunting its ability to help fight what medical professionals say is an oncoming wave of infections from the omicron variant. |
